Opinion: What being stricken with Covid-19 taught a biotech CEO
On March 14, at 10 a.m., I got the call that I had tested positive for SARS-CoV-2, the virus that causes Covid-19. At first, I was incredulous, trying to understand where I might have contracted it. Next, I got worried. Who had I been in contact with that I might have transmitted the virus to? Finally, I faced a nagging feeling that maybe, at 47 years of age and male, I might be at risk of a bad outcome.
I also had my company to think about. Apellis had more than 275 employees and two programs in Phase 3 clinical testing. I became gravely concerned about what a global pandemic would mean for our company. I also worried for our industry, as the complexities and hardships caused by the pandemic would not be specific to just our company.
Read Original Article: Opinion: What being stricken with Covid-19 taught a biotech CEO »
